4.8 Article

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Ferenc Emil Mozes et al.

Summary: Liver biopsy is still necessary for fibrosis staging in patients with non-alcoholic fatty liver disease. This study evaluated the diagnostic performance of liver stiffness measurement, FIB-4 Index, and NAFLD Fibrosis Score, and showed that sequential combinations of markers can reduce the need for liver biopsies.
Article Gastroenterology & Hepatology

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Tracey G. Simon et al.

Summary: Population-based data in Sweden showed that all histological stages of NAFLD were linked with significantly increased overall mortality, and the risk escalated progressively with worsening histology. Excess mortality was mainly attributed to extrahepatic cancer and cirrhosis, while cardiovascular disease and HCC made modest contributions.
Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Gastroenterology & Hepatology

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Emmanuel Anandraj Selvaraj et al.

Summary: Non-invasive tests measuring liver stiffness or using MRI have acceptable diagnostic accuracy for advanced fibrosis and cirrhosis. The potential clinical impact of these tests cannot be fully assessed due to lack of intention-to-diagnose analyses and validation of pre-specified thresholds.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

Fasiha Kanwal et al.

Summary: NAFLD is a common disease that affects a significant proportion of US adults. Management typically occurs in primary care or endocrine clinics, where accurate staging for fibrosis risk through screening is crucial, requiring consistent, timely, evidence-based, and easily testable management processes.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Review Medicine, General & Internal

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease

Anne-Marieke van Dijk et al.

Summary: In this study, FibroMeter versions were systematically reviewed for their performance in detecting different levels of fibrosis in patients with NAFLD. The findings indicated that FibroMeter VCTE had the highest diagnostic accuracy in detecting advanced fibrosis, followed by FibroMeter V2G and FibroMeter NAFLD, with no significant differences between the different versions. Head-to-head comparison studies are needed to further evaluate the performance of these tests.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Gastroenterology & Hepatology

Clinically Significant Fibrosis Is Associated With Longitudinal Increases in Fibrosis-4 and Nonalcoholic Fatty Liver Disease Fibrosis Scores

Preya Janubhai Patel et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

Hannes Hagstrom et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Ankur Srivastava et al.

JOURNAL OF HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Laurent Castera et al.

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

Jerome Boursier et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Exceeding the limits of liver histology markers

Shruti H. Melita et al.

JOURNAL OF HEPATOLOGY (2009)

Article Medical Laboratory Technology

Reproducibility of blood tests of liver fibrosis in clinical practice

Paul Cales et al.

CLINICAL BIOCHEMISTRY (2008)

Article Gastroenterology & Hepatology

Non-invasive evaluation of liver fibrosis using transient elastography

Laurent Castera et al.

JOURNAL OF HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Serum markers detect the presence of liver fibrosis: A cohort study

WMC Rosenberg et al.

GASTROENTEROLOGY (2004)